HITV Lab

Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Tuesday22 August 2017

Dr. Kenichiro Hasumi

ProfileBiographyPublication

Publication of Dr. Kenichiro HASUMI, M.D.

2013

Kenichiro Hasumi, Yumimasa Aoki, Ryuko Watanabe and Dean L Mann. Clinical Response of Advanced Cancer Patients to Cellular Immunotherapy and Intensity-Modulated Radiation Therapy. OncoImmunology 2:10, October 2013

2011

Kenichiro Hasumi, Yukimasa Aoki, Ryuko Watanabe, Kim G. Hankey and Dean L. Mann. Therapeutic Response in Patients with Advanced Malignancies  Treated with Combined Dendritic Cell-Activated T Cell Based Immunotherapy and Intensity-Modulated Radiotherapy. Cancers 2011, 3, 2223-2242

2010

Kenichiro Hasumi. Combining Conventional Therapies with Intratumoral Injection of Autologous immature Dendritic Cells (iDC) and Activated T Cell (AT) Therapy for Advanced Cancer Treatment. Integrative Medicine Japan. Vol. 3, No. 1: 47-55

2009

Dean L. Mann, Christina M. Celluzzi, Kim G. Hankey, Kristina M. Harris, Ryuko Watanabe, and Kenichiro Hasumi. Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers. Cancer Vaccines: Ann. N.Y. Acad. Sci. 1174: 41-50

2008

Chin-Hsuan Hsieh, Ya-Jan Hsu, Chien-Chung Chang, Hsin-Chun Liu, Kun-Lung Chuang, Cheng-Keng Chuang, See-Tong  Pang, Kenichiro Hasumi,  Soldano Ferrone, Shuen-Kuei Liao. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β 2 -microglobulin genes. Cancer Immunology Immunotherapy 58, 395-408

2008

Kristina M. Harris, Petra Lenz, Kim G. Hankey, Thomas MacVittie, Ann Farese, Kaori Nakajima, Kenichiro Hasumi and Dean L. Mann. Product of anti-CD3/anti-CD28 activated  lymphocytes  induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo. Clinical Immunology 129, 58-68

2007

K. Hasumi, Saigo Made Akiramenai Kanjyasan E, Saigo Made Akiramenai Isi Kara Okuru Aino Ganwakuchin.

2005

K. Hasumi, Meneki Ryoku De Gan To Tatakau.

2004

T. Sato, M. Terai, R. Yasuda, R. Watanabe, D. Berd, M. Mastrangelo, K. Hasumi. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach  to cancer immunotherapy. Cancer Immunology 53,53-61

2002

L. T. Harmison, K. Hasumi. Cancer Vaccines Zeroing in on the Cancer Cell

2002

K. Hasumi, Lovely Cancer Vaccine II.

2001

M. Sekiguchi, Y. Shiroko, T. Arai, T. Kishino, T. Sugawara, T. Kusakabe, T. Suzuki, T. Yamashita, T. Obara, K. Ito, K. Hasumi. Biological Characteristic and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines. Biomed Pharmacpther 55,466-74

2000

Y. Hirota, M. Haida, F. Mohtarami, K. Takeda, T. Iwamoto, S. Shioya, C. Tsuji, K. Hasumi, H. Nakazawa. Implication of ESR signals from ceruloplasmin (Cu²⁺ and transferrin  (Fe³⁺  ) in pleural effusion of lung diseases. Pathophysiology 7, 41-45

2000

Y. Fujii, H. Iwasa, J. Hirai, Y. Takahama, K. Hasumi, M. Eriguchi. Inhibition of Liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-δ-lactam(ND2001). Biomed & Pharmacother 54, 85-92

1999

Y. Fujii, H. Iwasa, J. Hirai, K. Hasumi, M. Eriguchi, Effects of HCFU and TNP 470 on liver metastasis of BALB/c retroperitoneal sarcoma. Gan to Kagaku Ryoho, 23-13

1997

M. Terai, R. Yasuda, R. Watanabe, K. Hasumi and H. Wago. Evaluation of Boving Spleen Alcoholic Extract on Survival of Tumor-Bearing Mice. Bull SMSJC, Vol.8, 13-18

1997

Y. Fujii, H. Itoyanagi, I. Hirose,  K. Hasumi, M. Eriguchi, Chaacterization of spontaneous liver metastatic model of BALB/c retroperitoneal sarcoma  (LMFS)  injected in footpad and antitumor effects of HCFU. Gan To Kagaku Ryoho, 24, 343-8

1996

K. Takeda, M. Haida, S. Shinoya, T. Matsumori, Y. Kimura and K. Hasumi. Estimation of the Malignancy of Pleural Effusions by Electron Spin  Resonance. Anal. Biochem., 241, 47-50

1995

H. Yanagie, Y. Fujii, Y. Takeda, S. Mikamo, I. Yoshizaki, N. Akiyama, M. Eriguchi and K. Hasumi. Report  of a case of Cystadenocartinoma of the liver  treated with extended left lobectomy. Jpn. J. Cancer Clin., 41, 1811-1816

1995

K. Takeda, M. Haida, S. Shioya, T. Matsumori, Y. Kimura and K. Hasumi. Electron spin resonance of pleural effusions obtained from cancer and non cancer patients. Magnt. Resn. in Medicine, 6, 246-248

1995

M. Sekiguchi, Y. Fujii, A. Saito, T. Suzuki, Y. Shiroko, H. Nakamura and K. Hasumi. Alpha-fetoprotein-producing gastric cacinoma: Biological properties of a cultured cell line. J. Gastroenterol, 30, 589-598

1994

Y. Fujii, H. Itoyanagi, Y. Saegusa, K. Hasumi and M. Eriguchi. Effect of 5'-DFUR against BALB/c retroperitoneal sarcoma with spontaneous liver metastases. Cancer & Immunotherapy, 21, 1627-1631

1994

Y. Fujii, K. Hasumi and M. Eriguchi. A case of small intestinal cancer with tubular adenoma. Oncologia, 27, 462-465

1994

Y. Fujii, T. Takahashi, Y. Takeda, K. Hasumi and M. Eriguchi. A case report of primary squamous cell carcinoma of the breast. Oncologia, 27, 71-74

1993

Y. Fujii, H. Itoyanagi, Y. Saegusa, M. Kuro-o, Y. Matsuda, Y. Shiroko, M. Eriguchi and K. Hasumi. Establishment and characterization of BALB/c retroperitoneal Sarcoma with spontaneous liver metastases. Jpn. J. Cancer Res., 84, 1055-1061

1993

Y. Takahama, Y. Fujii, H. Itoyanagi, H. Shimizu, M. J. Escribano, M. Eriguchi and K. Hasumi. Purification and molecular characterization  of  reto-acinar  pancreatic protein (FAP). Oncologia, 26, 587-593

1992

H. Nakamura, A. Masunaga, T. Yoshitake, K.  Hasumi, S. Itoyama  and I. Sugawara. Immunoelectron microscopic study of the lymphoid follicles in the thymus gland obtained from patients with Myasthenia gravis. J. Clin. Electron Microscopy, 25, 5-6

1992

K. Takeda, M. Haida, T. Matsumori, Y. Kimura, and K. Hasumi. Detection of stable radicals in malignant ascites and pleural effusion by electron spin resonance. Proc. Faculty Science, Tokai Univ., 27, 63-72

1992

Y. Fujii, K. Hasumi, H. Nakamura, Y. Takahama,  H. Shimizu,  I.  Sugawara,  M. Eriguchi and M. Sekiguchi. Characterization of a murine monoclonal antibody, 5D-4, reacting with pancreatic cancers and islets of langerhans. Biomed & Pharmacother, 46, 405-411

1991

H. Yanagie, T. Tomita, H. Kobayashi, Y. Fujii, T. Takahashi, K. Hasumi, H. Nariuchi, and M. Sekiguchi. Application of boronated anti-CEA immunoliposome to tumor cell growth inhibition in in vitro boron neutron capture therapy model. Br. J. Cancer, 63, 522-526

1991

Y. Fujii, Y. Yoshida, H. Shimizu, Y. Takahama, M. Eriguchi and K. Hasumi. The clinical significance of pancreatic cancer  associated antigen  1H1  in  cancer of pancreas-a comparative study with CA19/9 and CEA-. Oncologia, 24, 94-102

1991

K. Kozai, Y. Fujii, M. Eriguchi, H. Shimizu, N. Akiyama, Y. Samaru, M. Sekiguchi, H. Uchida, T. Wakabayashi, S. Mori, T. Takahashi and K. Hasumi. Two Cases of villous adnoma of sigmoid colon with focal carcinomas. Oncologia, 24-5, 108-112

1991

K. Hasumi, Lovely Cancer Vaccine.

1990

H. Nakamura, Y. Takahama, I. Sugawara, Y. Fujii, K. Hasumi and S. Itoyama. Cellular and tissue localization of antigens recognized by 5D-4 murine monoclonal antibody reactive with human langerhans' islands. J. Clin. Electron Microscopy, 23, 5-6

1990

H. Nakamura, Y. Morishita, I. Sugawara, Y. Fujii, K. Hasumi and S. Mori. Ultrastructural localization of antigens recognized by 5D-4 monoclonal antibody reactive with islets of langerhans. J. Clin. Electron Microscopy, 23, 393-398

1985

K. Hasumi, Ikiru.

HITV Lab

HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks